Supplemental Methods
Sample pre-processing for metagenomic sequencing Blood-EDTA samples were centrifuged at 2000 rpm for 20 min, the collected plasma was filtered using a 0.45 µm PES filter (TPP, Trasadingen, Switzerland) and aliquoted for subsequent storage at -80 °C.
Urine samples were filtered, aliquoted and stored. Next, a nuclease treatment with DNase and RNase was performed. Briefly, a nuclease mix containing 25 µL Turbo DNase (50 U, Ambion, Life Technologies), 10 µL RNase A (0.77 mg/mL, Qiagen, Hilden, Germany), 130 µL 10 X Turbo DNase buffer and 135 µL UltraPure DNase/RNase-free distilled water (Thermo Fisher Scientific, Waltham, MA) was added to 1000 µL of thawed patient sample. The reaction was incubated for 30 min at 37 °C using a thermoshaker at 1400 rpm.
Nucleic acid extraction
For extraction of total nucleic acids the NucliSENS EasyMAG system (BioMérieux, Craponne, France) was used according to manufacturer's instructions with an input volume of 1000 µL that was eluted in 25 µL for subsequent metagenomic sequencing. For sequence-specific qPCR, standard diagnostics input and elution volumes were used (input volume = 200 µL, elution volume = 110 µL).
Random, anchored nucleic acid amplification
Random, anchored amplification of total extracted nucleic acids was performed in separated reactions for RNA and DNA viruses [1] . For the RNA workflow, cDNA was generated by reverse transcription with a primer containing a random octamer linked to an anchor sequence ATCGTCGTCGTAGGCTGCTCNNNNNNNN [2] [3] [4] . 5 μL of eluate were used as template in a total volume of 20 μL, with 5 μM of random primer, 1 mM of dNTPs, 1x first strand buffer, 20 mM DTT, and 20 U/μL of SuperScript III (Invitrogen/Life Technologies). The template and random primers were heated at 65 °C for 5 min, followed by reverse transcription at 42 °C for 60 min and inactivation at 96 °C for 5 min. Prior to second strand synthesis, cDNA was denatured at 94 °C for 2 min and cooled down to 10 °C for 5 min. The second strand was synthesized with 5 U/μL DNA Polymerase I Large Klenow 2 Fragment (NEB Biolabs, Ipswich, MA) in 10x NEB buffer 2 in a final volume of 10 μL, at 37 °C for 30 min followed by an enzyme inactivation step at 75 °C for 20 min.
The DNA workflow started at the denaturation step at 94 °C for 2 min and was performed with the same random primer as used in the RNA workflow prior to second strand synthesis. Second strand synthesis was performed using the same conditions as described for the RNA workflow. Further amplification of RNA and DNA workflow products, utilizing the anchor primer and AmpliTaq Gold DNA Polymerase (Thermo Fisher Scientific), was performed as previously described [1] .
Metagenomic high-throughput sequencing
The quality and size of the anchor PCR products were assessed by capillary gel electrophoresis (Fragment Analyzer, Advanced Analytical, Ames, IA). PCR products were quantified with QuantiFluor 
Bioinformatic analysis
The obtained reads were processed with a dedicated bioinformatic pipeline "VirMet" version 1.1.1 developed in our laboratory (https://github.com/ozagordi/VirMet/releases/tag/v1.1.1) [5] . Briefly, reads were quality-filtered by removing low quality bases (average PHRED score below 20), reads shorter than 75 bp and reads with low entropy (i.e. consisting mainly of repeats). Reads passing quality filters were cleaned from non-viral reads by aligning with BWA MEM [6] against, in this order, human, bacterial, bovine and canine genomes. Reads not matching any of the above genomes were aligned with BLAST [7] against an in-house viral database that contains approximately 68'000 different virus sequences. For each sequencing read that passed the quality filter, the BLAST hit with lowest e-value was reported, given the coverage and identity were higher than 75%. Reads which did not match 3 genomes used in the cleaning step and did not match viral genomes included in the database were reported as of unknown origin.
Phylogenetic analysis of JCPyV isolates
Consensus sequences were constructed from JCPyV reads obtained for each patient using FreeBayes [8] and vcf2fasta (https://github.com/vcflib/vcflib#vcflib) as described in [9] .
Phylogenetic analysis of the full-length JCPyV consensus sequences was performed by using the Maximum likelihood method based on the Kimura 2-parameter model in the MEGA7 software (release 7161111). The partial-deletion option was used to remove positions with less than 95% site coverage before the analysis begins. In order to confirm reads obtained by metagenomic sequencing in blood and urine samples, qPCR against BKPyV was again performed as previously described in Hirsch et al. [10] . qPCR against JCPyV was carried out according to Gibson et al. [14] , however, modified primers within the target region were designed as follows: fwd primer: AGGCCCCCCTGAATACTTTC, rev primer:
Virus-specific qPCR for conventional monitoring of transplant recipients and confirmation of viral
AGGAATACTTGTTTTACAGTGCCTTGT and probe: FAM-CACTACTGCATATGGC-MGB.NFQ. qPCR against TTV and Human pegivirus (HPgV) was performed as described in [15] and [16] , respectively.
Copies/mL were calculated using a plasmid-based standard with a known concentration for TTV and HPgV (pAF121950) in every run. All qPCR analyses were performed using the TaqMan RNA-to-Ct 1-
Step In the context of conventional qPCR testing, viruses detected with less than 200 copies/mL were not quantified and reported as low positive.
Confirmation of Human papillomavirus (HPV) reads using patient-specific PCR
Patient specific primers were designed in order to confirm HPV sequencing results and PCRs were performed using Phusion Hot Start II High-Fidelity DNA Polymerase (Thermo Fisher Scientific), with cycling conditions according to manufacturer's instructions. Annealing temperatures were adjusted to respective primer pairs (see Suppl. Table 1 ).
